Clinically Meaningful Improvements in Urinary Incontinence Following Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study

Radomski S1, Ginsberg D2, Chapple C3, Sussman D4, Sand P5, Sievert K6, De Ridder D7, Jenkins B8, Zheng Y8, Nitti V9

Research Type


Abstract Category

Overactive Bladder

Abstract 166
Updates on the Use of Botulinum Toxin
Scientific Podium Short Oral Session 10
Wednesday 7th October 2015
14:22 - 14:30
Overactive Bladder Incontinence Detrusor Overactivity Clinical Trial
1. University of Toronto, 2. University of Southern California, 3. Sheffield Teaching Hospital, 4. Rowan University, 5. Evanston Continence Center, 6. University of Luebeck, 7. University Hospitals KU Leuven, 8. Allergan, Inc., 9. New York University Langone Medical Center

Sidney Radomski